A double blind placebo controlled study to establish the bifidogenic dose of inulin in healthy human Print E-mail

 

 

Eur J Clin Nutr. 2007 Oct;61(10):1189-95. Epub 2007 Jan 31.

 

A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans.

 

Kolida S, Meyer D, Gibson GR. Department of Food Biosciences, Food Microbial Sciences Unit, The University of Reading, Reading, UK. s.kolida@reading.ac.uk

 

 

OBJECTIVE: To evaluate the bifidogenic efficacy of two inulin doses in healthy human adults.

 

DESIGN: A double-blind, placebo-controlled, crossover human study.

 

SETTING: Food Microbial Sciences Unit, The University of Reading, Reading, UK.

 

SUBJECTS: Thirty healthy volunteers, 15 men, 15 women (age range 19-35).

 

INTERVENTIONS: Subjects consumed a chocolate drink containing placebo (maltodextrin, 8 g/day), 5 g/day inulin and 8 g/day inulin for a 2-week treatment period. Each treatment was followed by a 1-week washout at the end of which volunteers progressed to the next treatment. Faecal samples were obtained at the start of the study (baseline) and at the end of each treatment and washout period. Fluorescent in situ hybridization was used to monitor populations of Bifidobacterium genus, Bacteroides - Prevotella, Lactobacillus - Enterococcus and Clostridium perfringens - histolyticum subgroup.

 

RESULTS: Bifidobacterial levels increased significantly upon ingestion of both the low (9.78+/-0.29 log(10) cells/g faeces, P<0.05) and the high inulin dose (9.79+/-0.38 log(10) cells/g faeces, P=0.05) compared to placebo (9.64+/-0.23 log(10) cells/g faeces).

 

CONCLUSIONS: Both inulin doses exhibited a bifidogenic effect but a higher volunteer percentage responded to the high dose. A dose response effect was not observed but the magnitude of increase in bifidobacteria levels depended on their initial numbers. The higher the initial concentrations the smaller was the increase upon ingestion of the active treatments.

 

PMID: 17268410 [PubMed - indexed for MEDLINE]

 

 

 

{mosgoogle}

 

{mos_sb_discuss:11}

 


 

Comments (0)Add Comment

Write comment

busy
 

 

Latest Comments

EiR on Facebook

Follow us on Facebook

EiR on Twitter


Follow The EiR on Twitter

Online Members

4 users online